Critical SP500 Stock Alerts: Citigroup, EMC, AbbVie, Mondelez International, U.S. Bancorp, and KeyCorp



Insiderslab.com has issued insider trading reports and equity research for the following companies: Citigroup (NYSE:C), EMC (NYSE:EMC), AbbVie (NYSE:ABBV), Mondelez International (NASDAQ:MDLZ), U.S. Bancorp (NYSE:USB), and KeyCorp (NYSE:KEY).
 
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
 
Report Highlights:
 
Citigroup Inc. (NYSE:C): Earlier this month, Citigroup Inc. (NYSE:C) announced the appointment of Jamie Forese and Manuel Medina-Mora as Co-Presidents. Moreover, Jim Cowles has been named as Chief Executive Officer of Citi’s Europe, Middle East and Africa region. What’s more, Hamid Biglari, the Head of emerging markets, is leaving the bank, Chief Executive Michael Corbat announced on Monday. Investors may want to find out how Citigroup insiders are thinking about the future of the company. Check this insider trade report for C here.
 
Read Full Report: http://www.insiderslab.com/PR3/011713A/C/Citigroup.pdf
 
EMC Corporation (NYSE:EMC): In the last three months, EMC Corporation (NYSE:EMC) insiders have totally sold US$20.44 million worth of stock, which ranged in price from US$24.69 to US$25.15 each, according to insider trading report. On January 16, the company announced significant hardware and software updates to its market-leading EMC VMAX Family. The EMC VMAX 10K, the entry product to the VMAX Family, is the current’s highest-performing of its class in the industry-and is up to twice more powerful than its predecessor. See insider trade report for EMC here.
 
Read Full Report: http://www.insiderslab.com/PR3/011713A/EMC/EMC.pdf
 
AbbVie Inc. (NYSE:ABBV): AbbVie Inc. (NYSE:ABBV) is a research-based biopharmaceutical company formed in 2013 following separation from Abbott. Earlier this month, AbbVie’s Board of Directors declared its first quarterly cash dividend of US$0.40 per share, payable on February 15, 2013 to stockholders of record on January 15, 2013. The company will post its financial results for fourth quarter and full year 2012 on Wednesday, January 23. Check this insider trade report for ABBV here.
 
Read Full Report: http://www.insiderslab.com/PR3/011713A/ABBV/AbbVie.pdf
 
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
 
Mondelez International Inc. (NASDAQ:MDLZ):
Read Full Report: http://www.insiderslab.com/PR3/011713A/MDLZ/MondelezInternational.pdf
 
U.S. Bancorp (NYSE:USB):
Read Full Report: http://www.insiderslab.com/PR3/011713A/USB/USBancorp.pdf
 
KeyCorp (NYSE:KEY):
Read Full Report: http://www.insiderslab.com/PR3/011713A/KEY/KeyCorp.pdf
 
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
 
About Insiderslab.com:
 
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore.  Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
 
Important Disclaimer:
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
 
CONTACT: Insiders.hk, Insiderslab.com, info@insiderslab.com, Support@insiders.hk
SOURCE Insiderslab.com; Insiders.hk
Editor: Janet Nan Jiang
 
 
Source:
insiderslab.com
www.insiderslab.com

Reported on Jan 17, 2013

 
More Insider News ...

Today's Notable Trades


UNIVERSAL ELECTRONICS INC (UEIC)
Director: MULLIGAN WILLIAM C

Acquired 1,250 Common Stock (Non-Derivative security at $49.840) on Sep 30, 2014. Direct holding 11,816 shares/units after transaction. Holdings increased 11.83%.
Filing date: Oct 1, 2014. Record updated at 22:35:46.
 
PACIFIC MERCANTILE BANCORP (PMBC)
Senior Officer (CEO Emeritus): DELLERBA RAYMOND E

Acquired 40,000 Common Stock (Non-Derivative security at $3.740) on Oct 1, 2014. Direct holding 48,326 shares/units after transaction. Holdings increased 480.42%.
Filing date: Oct 1, 2014. Record updated at 22:27:45.
 
VOCERA COMMUNICATIONS, INC. (VCRA)
First-Class Insider (President & CEO): LANG BRENT D.

Acquired 29,167 Common Stock (Non-Derivative security at $1.080) on Sep 29, 2014. Direct holding 172,930 shares/units after transaction. Holdings increased 20.29%.
Filing date: Oct 1, 2014. Record updated at 22:23:11.
 
ARROWHEAD RESEARCH CORP (ARWR)
Director: McKenney Charles

Acquired 2,500 Common Stock (Non-Derivative security at $5.190) on Oct 1, 2014. Direct holding 19,720 shares/units after transaction. Holdings increased 14.52%.
Filing date: Oct 1, 2014. Record updated at 22:21:04.
 
AMICUS THERAPEUTICS INC (FOLD)
Senior Officer (VP Finance and Controller): Quimi Daphne

Acquired 10,738 Common stock (Non-Derivative security at $6.097) on Sep 29, 2014. Direct holding 60,738 shares/units after transaction. Holdings increased 21.48%.
Filing date: Oct 1, 2014. Record updated at 22:20:10.
 
zulily, inc. (ZU)
Senior Officer (Chief Merchant): Twomey Lori

Sold 50,000 Class A Common Stock (Non-Derivative security at $40.325) on Sep 29, 2014. Direct holding 0 shares/units after transaction. Holdings decreased -100.00%.
Filing date: Oct 1, 2014. Record updated at 22:18:56.
 
DreamWorks Animation SKG, Inc. (DWA)
First-Class Insider (Chief Executive Officer): KATZENBERG JEFFREY

Acquired 423,214 Class A Common Stock, par value $0.01 per share (Non-Derivative security at $28.000) on Sep 29, 2014. Direct holding 641,624 shares/units after transaction. Holdings increased 193.77%.
Filing date: Oct 1, 2014. Record updated at 22:18:02.
 
CHURCHILL DOWNS INC (CHDN)
Senior Officer (President and Chief Operating): Carstanjen William C

Sold 11,284 Common Stock (Non-Derivative security at $97.040) on Sep 29, 2014. Direct holding 99,565 shares/units after transaction. Holdings decreased -10.18%.
Filing date: Oct 1, 2014. Record updated at 22:17:44.
 
INTERMUNE INC (ITMN)
First-Class Insider (Chairman, CEO and President): WELCH DANIEL G

Sold 71,202 Common stock (Non-Derivative security at $74.000) on Sep 29, 2014. Direct holding 23,000 shares/units after transaction. Holdings decreased -75.58%.
Filing date: Oct 1, 2014. Record updated at 22:14:33.
 
Vitae Pharmaceuticals, Inc (VTAE)
10% shareholder: PROSPECT MANAGEMENT CO II LLC

Acquired 671,807 Common Stock (Non-Derivative security at $8.000) on Sep 29, 2014. Indirect holding 2,572,523 shares/units after transaction. Holdings increased 35.34%.
Filing date: Sep 30, 2014. Record updated at 22:09:34.
 
Read more

Disclaimer

InsidersLab.com focuses on tracking and monitoring insider trading activities in the US stocks market. "Insider Trading" means trading activities created by company directors, senior officers, individual substantial shareholders, and institutional shareholders. InsidersLab.com does not represent, warrant, nor endorse the accuracy, reliability, completeness or timeliness of any of the information, content, views, opinions, recommendations or advertisements (collectively, the "Materials") contained on, distributed through, or linked, downloaded or accessed from any of the services contained on the website (the "Service"), nor the quality of any products, information or other materials displayed, purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection with the Service (the "Products"). InsidersLab.com collects insider trading information from different public sources such as newspapers, financial information websites, and government statistics publications. You hereby acknowledge that any reliance upon any Materials shall be at your sole risk. In particular, none of the Materials is provided on the InsidersLab.com website or emails with a view to inviting, inducing or encouraging any person to make any kind of investment decision. Securities or other investments referred to in the Materials may not be suitable for you and you should not make any kind of investment decision in relation to them without first obtaining independent investment advice from a person authorized to give it.